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Background: The purpose of this study was to carry out a cross-cultural adaptation to Brazilian Portuguese,
validation, and comparison of two questionnaires to measure adherence in patients with type 1 diabetes. There are
no validated instruments to measure treatment adherence in Brazilian patients with type 1 diabetes.
Methods: Type 1 diabetes outpatients of a tertiary hospital in Southern Brazil were recruited to examine
psychometric properties of the Diabetes Self-Management Profile (DSMP) and Self-Care Inventory-revised (SCI-R)
adapted to Brazilian Portuguese. Analyses assessed the reliability and validity according to its associations with
glycated hemoglobin (A1C). Seventy-five patients [age: 34.9 ± 13.7 years; A1C: 9.2 ± 2% (75 mmol/mol); diabetes
duration: 18.1 ± 11.8 years] were evaluated.
Results: The translated versions of the instruments showed adequate internal consistency (DSMP Cronbach’s
α =0.76; SCI-R Cronbach’s α =0.71). A positive correlation was found between all the items and total scores, except for
item 12 in DSMP and item 13 in SCI-R, and for this reason, these items were excluded from the translated versions.
In predictive validity analysis, A1C correlated significantly with the DSMP total (r = −0.46) and with the SCI-R
total (r = −0.44).
Conclusions: The Brazilian Portuguese versions of DSMP and SCI-R yielded a reliable and valid tool to measure
adherence treatment for patients with type 1 diabetes, with a significant correlation between total scores and A1C.
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Brazil is the fifth largest country in the world, with an
estimated population of 191 million [1]. Recent data sug-
gests that 2.5 million Brazilians live abroad, of which,
over one million in the United States of America [2].
Diabetes affects 8.3% of the population, which contrib-
utes to why it is one of the leading causes of premature
illness and mortality [3]. The global variation in the inci-
dence of type 1 diabetes is known to be high [4,5]. In
Brazil, the estimated incidence of type 1 diabetes (27.20/
100,000 per year) is considered very high and is increas-
ing, and a wide variation is observed between and within* Correspondence: gabrielatelo@yahoo.com.br
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unless otherwise stated.ethnic groups, with higher incidence in Caucasians [6]
(54% of the Brazilian population) [7].
Major clinical trials of type 1 diabetes have demon-
strated the benefits of intensive glycemic control in pre-
venting chronic diabetes complications [8,9]. To prevent
serious morbidity and mortality, diabetes treatment re-
quires dedication to demanding self-care behaviors in
multiple domains, including diet plan, physical activity,
medications, glucose monitoring and symptom manage-
ment [10]. Among strategies to achieve glycemic targets,
improving adherence to diabetes-related tasks is very
important, as it predicts glycemic control and healthy
outcomes [9,11]. Published estimates of non-adherence
rates have ranged from 40% to 90% across studies and
measures, contributing to poor glucose control [12,13].
A recent nationwide multicenter study in Brazil reported
that only 13.2% of patients with type 1 diabetes were atis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Diabetes Association [15]. This finding was associated
with lower economic status; however, no data were avail-
able about adherence to diabetes management [14,16].
At a public hospital in Southern Brazil, non-adherence was
the most common precipitating factor of diabetic ketoaci-
dosis, responsible for 49% of this emergency hospitalization
[17]. Moreover, medication noncompliance was associated
with 41% higher inpatient costs [18] and a better adher-
ence was found to be associated with improved glycemic
control and decreased health care resource utilization
[10], resulting in an annual estimated cost savings of $1
billion [18].
Despite the well-known importance of adherence in dia-
betes treatments and tasks in order to achieve expected
goals to prevent chronic complications, there are few
easy-to-use instruments with established psychometric
properties to assess it. The Diabetes Self-Management
Profile (DSMP) is a validated, semi-structured interview
that extensively measures adherence to type 1 diabetes
management tasks over the previous 3 months [19]. It re-
quires 30–40 min to be administered, and because of the
long duration its use in clinical care may not be practical.
A concise version was developed [20], but with decreased
internal consistency. The Self-Care Inventory-revised
(SCI-R) is a brief, psychometrically sound measure of per-
ceptions of adherence to recommended diabetes self-care
behaviors of patients with diabetes [21], but more superfi-
cially explores each item related to non-adherence.
There is no instrument to measure adherence to the
treatment of type 1 diabetes adapted to Brazil. The aim
of this study was to adapt to Brazilian Portuguese, valid-
ate, and compare the two main available instruments.
One of them is easy to use in clinical practice and the
other is more complete with useful information for clin-
ical research purposes.Methods
Participants
This study was carried out in a diabetes outpatient clinic
of a university hospital in Brazil from June to December
2012. Eligibility criteria included: ages 11 and older [19];
previous diagnosis of type 1 diabetes; disease duration of
at least 12 months; and Brazilian nationality. The exclu-
sion criteria were a development disability or a psychi-
atric disorder that would be an obstacle in completing
the structured interview. Patients were searched for in the
hospital’s medical record database, and those who met
these criteria were given study information. Interested eli-
gible patients or their legal guardians signed an informed
consent form, conforming to the Helsinki Declaration of
1975, as revised in 2000 and 2008. This study was previ-
ously approved by the Institutional Ethics Committee.Instruments
The authors of the original questionnaires were asked per-
mission by email, and the study began only after their
authorization. In this study, two instruments were ran-
domly applied by two interviewers, both well-advised of the
research objectives and trained in order to maintain a neu-
tral position while the patients filled out the questionnaires.
The DSMP, originally validated by Harris et al., is a
structured interview developed to assess self-management
among young patients with type 1 diabetes. It consists of
25 items measuring 5 domains: exercise, hypoglycemia,
diet, blood glucose test, and insulin dose. This instrument
has revealed adequate internal consistency, inter-rater
agreement and test-retest reliability, in addition to a cor-
relation with glucose control, measured by A1C [19].
These results were maintained in cross-cultural adapta-
tions thereafter [22].
The SCI-R, validated by La Greca et al., is a 15-item
questionnaire, on a 5-point Likert scale that reflects how
well the subjects followed recommendations for self-care
during the past month (i.e., 1 = “never” to 5 = “always”).
The measure requires 10–15 min to be applied, and has
acceptable internal reliability and correlation between gly-
cemic control and total score [21]. In both instruments
higher scores indicate more meticulous self-management.
After the questionnaires were administered, researchers
interviewed the patients to obtain information about clin-
ical and demographic data. Economic status was defined
in accordance with the Brazilian Economic Classification
Criteria [23]. A1C (high-performance liquid chromatog-
raphy method) was obtained from the patients records
over the past 3 months and if not available, from a new
blood sample.
Procedures and measures
The initial translation of the original instruments into
Brazilian Portuguese was performed by two independ-
ent translators who were native speakers of Brazilian
Portuguese, were fluent in both languages and had dif-
ferent professional profiles from the researchers. One
was aware of the underlying objectives of the instruments
to be translated and the concepts involved in order to
offer a more reliable restitution of the intended measure-
ment. Resulting synthesis versions were obtained, and the
words and phrases that presented differences were con-
sensually readapted and defined by the translators [24].
The synthesis version of the instruments was back-
translated by two independent translators, who were na-
tive speakers of English as well as fluent in both languages.
Neither of them were aware of the underlying objectives
of the instruments [24,25].
Based on the translations and back-translations ob-
tained, a committee was assembled, in a face-to-face meet-
ing, in order to produce a final version of the modified
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gists (including the principal investigator), the four trans-
lators involved, all bilinguals and one of them a specialist
in Linguistics. The committee carefully considered each of
the items of the instruments in order to better adapt them,
with the goal of ensuring that the translation is fully com-
prehensible and verifying cross-cultural equivalence of
source and final version, considering semantic, idiomatic,
experiential and conceptual equivalence [25].
The final stage of adaptation process was the pretest
of the new questionnaires, applied in 40 previously se-
lected patients [24]. The subjects completed the instru-
ments and were interviewed to find out what they
thought was meant by each questionnaire item and their
chosen response [24,25]. The cognitive debriefing was used
to generate a final version of the translated instruments,
based on participants’ feedback, to confirm the acceptabil-
ity of the translation. Test-retest reliability over 3 months
was determined in order to stabilize the sample and to
check the intra-observer variability [19,24]. Upon comple-
tion of this cross-cultural adaptation, in order to verify that
the instruments lead to valid conclusions, analyses were
conducted on 75 patients (including the 40 initially
evaluated) [26] to assess the construct and discriminant
validity [24,25]. All patients answered the same ques-
tions with a second interviewer, within 1 to 2 weeks of
the previous evaluation, in order to evaluate the inter-
rater agreement [19].Table 1 Clinical and demographic data of the study
population
Variable N = 75
Gender, f (%) 42 (56)
Age, y 34.9 ± 13.7












Years of study 10.7 ± 4.0
A1C, % (mmol/mol) 9.2 ± 2.0 (77)
Data presented as number (%), mean ± SD, median and 25% and 75% quartiles;
f = female, y = years.
*High (A1, A2, B1), medium (B2, C1), low (C2) and very low (D, E).Data analysis
Data are presented as mean ± standard deviation (SD) or
percentage, and median and interquartile range (25 and
75 percentiles). Statistical analyses employed SPSS 19.0 and
the level of significance was defined as α =0.05. T-test and
Mann–Whitney were used to analyze quantitative data,
and Chi-square test was used for categorical variables.
Cronbach’s α was calculated to measure internal
consistency, and item-total correlations were computed.
In this analysis, values above 0.7 were considered accept-
able [25]. In addition, we analyzed the impact of removal
of each question on the value of Cronbach’s α, which
could lead to the exclusion of a particular item. A
confirmatory factor analysis was used to evaluate it.
Test-retest and inter-rater agreement were measured by
intraclass correlation coefficient.
Pearson correlation coefficient was used to examine
predictive validity between the instruments total scores
and A1C, and convergent validity between DSMP and
SCI-R scores. Dichotomization of the scores into poor
[A1C ≥8% (≥64 mmol/mol)] and good glucose control
[A1C <8% (<64 mmol/mol)] [27] was performed to
evaluate the best cutoff to discriminate it, using receiver
operating characteristic (ROC) curve.Results
Descriptive statistics
The initial search of medical records included 123 pa-
tients, from which 44 declined to participate, 3 were ex-
cluded because of developmental disabilities and another
was excluded for not returning in subsequent reevaluation.
The sample consisted of 75 subjects 34.9 ± 13.7 years of
age, 66% female and 89% Caucasian. Mean participant
duration of diabetes was 18.1 ± 11.8 years, and A1C was
9.2 ± 2.0% (77 mmol/mol). Other characteristics are avail-
able in Table 1.
Reliability
The original Brazilian Portuguese version of the DSMP
was composed of 25 items, and could be completed in ap-
proximately 20 min. Item-total correlations were calcu-
lated separately for each item in the Brazilian Portuguese
version of the questionnaires. All item-total correlations,
except one, were in the expected direction, ranging from
0.01 to 0.76. Confirmatory factor analysis was conducted
to examine an “a priori” five-factor structure, which con-
sisted of each subscale identified as a factor. The same
item did not load onto the factor for this version and was
eliminated [In the past 3 months, how often have you
eaten less than what is recommended for your meal
plan?], which increased Cronbach’s α from 0.74 to 0.76.
Internal consistency (Cronbach’s α) of the DSMP subscales
was all <0.7, indicating that the subscales are not reliable
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and subscale scores were as follows: exercise, r = 0.27
(P = 0.02); hypoglycemia, r = 0.65 (P <0.01); diet, r =
0.72 (P <0.01); blood glucose test, r = 0.88 (P <0.01);
and insulin dose, r = 0.62 (P <0.01). On the SCI-R,
Cronbach’s α was initially 0.69, with all item-total corre-
lations in the expected direction, ranging from 0.01 to
0.65. The removal of one item [Wear a medic alert ID] led
to a significant increase in internal consistency, therefore
it was excluded. The final Cronbach’s α was 0.71 (Table 2).
The application of this 14-question translated version took
less than 10 min.
Inter-rater agreement was established through two inde-
pendent interviews of all participants and by calculating
intraclass correlation coefficient. Inter-rater agreement
was 0.91 on the DSMP and 0.92 on the SCI-R.
Test-retest reliability over 3 months was determined
using data from the first 40 patients. The intraclass correl-
ation coefficient between the baseline and 3-month scores
on the DSMP was 0.99 (exercises, 0.99; hypoglycemia,
0.99; diet, 0.60; blood glucose test, 0.99; insulin dose, 0.97)
and on the SCI-R it was 0.99.
Validity
Predictive validity was determined by correlating DSMP
and SCI-R scores with A1C results. A1C correlated sig-
nificantly with the DSMP total (r = −0.46, P <0.01), as
well as with 3 of the 5 subscales (diet, r = −0.42; blood
glucose test, r = 0.40; insulin dose, r = 0.40, P <0.01) and
with the total SCI-R (r = −0.44, P <0.01).
In the analysis of convergent validity, a strong correl-
ation (r = 0.88, P <0.01) was found between the DSMP
and the SCI-R scores.
Mean DSMP total scores were 41.4 ± 10.6, and the best
cutoff value for classifying a patient as having a higher
or lower adherence score, considering A1C results, was
41 (area under the ROC-curve = 0.73, P <0.01), where
higher scores indicate greater adherence. The mean of
SCI-R total scores was 47.8 ± 8.1, in which the best cutoff
value for classifying a patient as having a higher or lowerTable 2 Technical features, psychometric properties and
predictive validity of the Brazilian versions of the DSMP
and SCI-R (N = 75)
DSMP SCI-R
Items (n) 24 14
Application time (min) 20-30 8-10
Mean total score 41.4 ± 10.6 47.8 ± 8.1
Cronbach’s α 0.76 0.71
Correlation with A1C (r) −0.46 −0.44
Cutoff value for non-adherence ≤ 41 ≤ 48
Data presented as number (%), mean ± SD; r = Pearson correlation coefficient.
DSMP: Diabetes Self-Management Profile; SCI-R: Self-Care Inventory-revised.adherence score was 48 (area under ROC-curve = 0.71,
P <0.01), where higher scores also indicate greater adher-
ence [27]. There were no significant clinical or demo-
graphic differences between both groups based on these
classifications (Table 3).
Discussion
The results of the present study provided support for the
validity of a Brazilian Portuguese version of two measuring
adherence instruments for patients with type 1 diabetes,
DSMP and SCI-R, indicating that they could be used reli-
ably in future studies.
The reliability of both instruments was evaluated using
several methods. Cronbach’s α was acceptable for both
and similar to the original version of the DSMP [19], sug-
gesting that, despite modifications, the scales remained in-
ternally consistent. A better value was found in the
original SCI-R (Cronbach’s α = 0.87), however it also in-
cluded patients with type 2 diabetes [21]. Furthermore,
agreement was found between the two independent raters
in total scores as well as in the five subscales of DSMP.
The test-retest reliability over 3 months was higher than
0.9 in total scores and in all of the subscales of DSMP, with
the exception of one, diet, a finding we attributed to long
period between assessments and seasonal dietary varia-
tions [28] considering that this study started in the winter
and finished in the summer. In both instruments, we ex-
cluded one item due to lack of benefit as well as a signifi-
cant improvement in reliability after their exclusion. In the
United Kingdom version of SCI-R, the same item was
excluded [29].
Diabetes Self-Management Profile and SCI-R scores
obtained from the original instruments correlated sig-
nificantly with A1C in the expected direction, under-
scoring the importance of evaluating adherence in these
patients, as it is correlated with glucose control [11]. It
demonstrated that more careful self-management of dia-
betes was associated with better glycemic control. This
study found a stronger correlation between total scores
and A1C than the original instruments (r = −0.28 for
DSMP and r = −0.37 for SCI-R) [19,21], which could be
related to having the same time period between A1C sam-
ple and questionnaire application, a reliable method for
measuring A1C [15], and extensive interviewer training.
High concordance with the original versions of both
instruments was found in the translated measures in this
study. Forward and back-translations were used to main-
tain semantic and conceptual equivalence, allowing bet-
ter analysis of adherence in Brazilian patients with type
1 diabetes. Mean SCI-R score in Brazil was much lower
than that of the English version (65 ± 15) [21], as well as
the mean DSMP score (58.5 ± 9.1). This finding is con-
sistent with the results presented by Gomes et al. [14],
who examined the prevalence of Brazilian adults with
Table 3 Clinical and demographic differences between patients with different adherence profiles* (N =75)
Variable DSMP P SCI-R P
Lower adherence score Higher adherence score Lower adherence score Higher adherence score
N (%) 36 (48) 39 (52) 33 (44) 42 (56)
Gender, f 21 (58.3) 21 (53.8) 0.67 20 (60.6) 22 (52.4) 0.50
Age, y 33.7 ± 13.3 35.0 ± 14.1 0.91 32.6 ± 12.0 36.7 ± 14.8 0.15
Duration of diabetes, y 16.7 ± 13.7 19.4 ± 9.8 0.09 15.6 ± 11.3 20.1 ± 11.9 0.06
Caucasian 30 (83.3) 37 (94.9) 0.09 29 (87.9) 38 (90.5) 0.34
Years of study 10.0 ± 3.6 11.4 ± 4.1 0.94 9.4 ± 3.72 11.7 ± 3.8 0.60
Diabetes complications 14 (38.9) 14 (35.9) 0.97 13 (39.4) 15 (35.7) 0.86
BMI, kg/m2 24.2 ± 3.6 25.1 ± 4.0 0.44 24.1 ± 3.3 25.0 ± 4.1 0.64
Data presented as number (%), mean ± SD, median and 25% and 75% quartiles; f = female, y = years, BMI = body mass index. DSMP: Diabetes Self-Management
Profile; SCI-R: Self-Care Inventory-revised.
*Based on best cutoff for classifying a patient as having a higher adherence score (≥41 for DSMP and ≥48 for SCI-R).
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ical practice, and found that only 13.2% achieve them.
Considering the fact that the treatment guidelines of the
Brazilian Diabetes Society [30] are essentially the same as
those of the American Diabetes Association [15], other
factors such as, noncompliance, low educational level and
poor economic income might interfere with diabetes care
in Brazil.
Using the available validated instruments, we evaluated
their possible ability to discriminate between patients
with a better or worse adherence profile, dichotomizing
them into poor and good controls [27]. We found statis-
tically significant cutoffs, which may be useful in the in-
terpretation of the scores during the application of the
instruments in clinical or research settings. The results
point out that 41 and 48 were the best cutoff points for
DSMP and SCI-R scores, respectively.
There are a number of limitations in this study. First,
the Brazilian Portuguese version of DSMP was adapted
from the original English version, however it included
two versions, one for the patients and one for their par-
ents [19]. We decided to adapt only the patient version,
aiming to obtain information directly from patients
about their diabetes care. Moreover, although our sam-
ple was older than the sample in the English DSMP pub-
lication, patients with the same age range were included.
The reason for this is because our institution predomin-
antly provides diabetes care for adult patients. Neverthe-
less, the results we encountered were similar to those
found in the original version of the DSMP. Regarding
SCI-R, it primarily evaluates patients with type 1 and
type 2 diabetes, including youth and adults [21]. As our
study intended to assess compliance of patients with
type 1 only, we did not include patients with type 2 dia-
betes, and it may have led to different results when com-
pared to the original version. In addition, our sample
size was calculated based on literature recommendations
for studies with this methodology [26], and not based onpossible differences between patients with better and
worse adherence profile. This may be the reason why we
did not find statistically significant clinical or demographic
differences between patients with high and low adherence
scores. On the other hand, in a meta-analysis that evalu-
ated adherence and glycemic control in pediatric type 1
diabetes patients, no socio-demographic or disease charac-
teristics were associated with noncompliance, suggesting
that all patients should experience better glycemic out-
comes with adherence promotion [11]. Finally, we verified
the sensitivity of the instruments to detect differences be-
tween groups. In the absence of a gold standard, we opted
to use A1C as a parameter to differentiate the groups,
considering its importance as an indicator of metabolic
control [15] and the high correlation reported between
metabolic control and adherence [11]. Nevertheless, the
correct methodology implemented allows us to validate
the results.
Conclusion
In conclusion, the Brazilian Portuguese adapted versions
of the evaluated instruments demonstrated acceptable
psychometric properties and validity with similar results.
Both of them can provide an important alternative to as-
sist researchers in the assessment and interpretation of
treatment adherence in patients with type 1 diabetes.
However, considering the similar results between both
surveys and the shorter time for administration of the
SCI-R, this questionnaire could be a better option in the
clinic right away.
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